283 related articles for article (PubMed ID: 29422069)
1. IL-1 family cytokines and soluble receptors in systemic lupus erythematosus.
Italiani P; Manca ML; Angelotti F; Melillo D; Pratesi F; Puxeddu I; Boraschi D; Migliorini P
Arthritis Res Ther; 2018 Feb; 20(1):27. PubMed ID: 29422069
[TBL] [Abstract][Full Text] [Related]
2. IL-1 family cytokines and receptors in IgG4-related disease.
Capecchi R; Italiani P; Puxeddu I; Pratesi F; Tavoni A; Boraschi D; Migliorini P
Cytokine; 2018 Feb; 102():145-148. PubMed ID: 28823915
[TBL] [Abstract][Full Text] [Related]
3. Cytokines and soluble receptors of the interleukin-1 family in Schnitzler syndrome.
Migliorini P; Italiani P; Pratesi F; Puxeddu I; Boraschi D
Scand J Rheumatol; 2019 May; 48(3):235-238. PubMed ID: 30668200
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of IL-1 family cytokines and receptors in Alzheimer's disease: new markers of disease progression?
Italiani P; Puxeddu I; Napoletano S; Scala E; Melillo D; Manocchio S; Angiolillo A; Migliorini P; Boraschi D; Vitale E; Di Costanzo A
J Neuroinflammation; 2018 Dec; 15(1):342. PubMed ID: 30541566
[TBL] [Abstract][Full Text] [Related]
5. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus.
Davas EM; Tsirogianni A; Kappou I; Karamitsos D; Economidou I; Dantis PC
Clin Rheumatol; 1999; 18(1):17-22. PubMed ID: 10088943
[TBL] [Abstract][Full Text] [Related]
6. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
[TBL] [Abstract][Full Text] [Related]
8. Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus.
Sturfelt G; Roux-Lombard P; Wollheim FA; Dayer JM
Br J Rheumatol; 1997 Dec; 36(12):1283-9. PubMed ID: 9448589
[TBL] [Abstract][Full Text] [Related]
9. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
Lim KL; Jones AC; Brown NS; Powell RJ
Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
[TBL] [Abstract][Full Text] [Related]
11. Correlation of Serum Soluble Interleukin-7 Receptor and Anti-C1q Antibody in Patients with Systemic Lupus Erythematosus.
Chi S; Xue J; Li F; Zhu C; Yu Y; Li H; Wang X; Zhang Y; Yang J; Zhou S; Yang L; Ji C; Liu X
Autoimmune Dis; 2016; 2016():8252605. PubMed ID: 27069677
[TBL] [Abstract][Full Text] [Related]
12. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble interleukin 7 receptor is strongly associated with lupus nephritis in patients with systemic lupus erythematosus.
Badot V; Luijten RK; van Roon JA; Depresseux G; Aydin S; Van den Eynde BJ; Houssiau FA; Lauwerys BR
Ann Rheum Dis; 2013 Mar; 72(3):453-6. PubMed ID: 23264357
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of selected disease activity markers in patients with systemic lupus erythematosus.
Horák P; Scudla V; Hermanovó Z; Pospisil Z; Faltýnek L; Budiková M; Kusá L
Clin Rheumatol; 2001; 20(5):337-44. PubMed ID: 11642515
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
[TBL] [Abstract][Full Text] [Related]
16. [Neopterin and a soluble interleukin-2 receptor in patients with systemic lupus erythematodes].
Horák P; Hermanová Z; Ordeltová M; Faltýnek L; Kusá L; Budíková M; Vavrdová V; Opíchalová D; Ciferská H; Scudla V
Vnitr Lek; 2004 Jun; 50(6):422-7. PubMed ID: 15346634
[TBL] [Abstract][Full Text] [Related]
17. [The importance of determination of interleukin-10 in the blood of patients with systemic lupus erythematosus].
Scudla V; Horák P; Faltýnek L; Pospísil Z; Budíková M; Hermanová Z
Cas Lek Cesk; 1998 Jan; 137(2):44-7. PubMed ID: 9511265
[TBL] [Abstract][Full Text] [Related]
18. Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus.
Brilland B; Bach-Bunner M; Gomes CN; Larochette V; Foucher E; Plaisance M; Saulnier P; Costedoat-Chalumeau N; Ghillani P; Belizna C; Delneste Y; Augusto JF; Jeannin P
Front Immunol; 2021; 12():663192. PubMed ID: 34054830
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
[TBL] [Abstract][Full Text] [Related]
20. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
